Endocrine Abstracts

Background: To determine the safety and efficacy of Yttrium 90 (Y90) transarterial radioembolizations (TARE) for neuroendocrine liver metastasis (NLM) and elucidate factors that affect outcomes.Methods: Retrospective analysis of 39 patients with NLM in a single center who underwent 65 Y90 TAREs with glass or resin microspheres between April 2012 and December 2022. There were 17 male and 22 female with a mean age at time of treatment of 65.5 years (SD &pm...